These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8131286)

  • 1. Rapid screening for p53 mutations with a sensitive heteroduplex detection technique.
    Tsongalis GJ; Kaufmann WK; Wilson SJ; Friedman KJ; Silverman LM
    Clin Chem; 1994 Mar; 40(3):485-6. PubMed ID: 8131286
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations.
    Keller G; Hartmann A; Mueller J; Höfler H
    Lab Invest; 2001 Dec; 81(12):1735-7. PubMed ID: 11742044
    [No Abstract]   [Full Text] [Related]  

  • 4. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming complexities in genetic screening for cancer susceptibility.
    Friend SH; Iggo R; Ishioka C; Fitzgerald M; Hoover I; O'Neill E; Frebourg T
    Cold Spring Harb Symp Quant Biol; 1994; 59():673-6. PubMed ID: 7587129
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
    Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
    Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four novel germ-line mutations in the APC gene detected by heteroduplex analysis.
    Hamzehloei T; West SP; Chapman PD; Burn J; Curtis A
    Hum Mol Genet; 1994 Jun; 3(6):1023-4. PubMed ID: 7951218
    [No Abstract]   [Full Text] [Related]  

  • 10. A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors.
    Gutiérrez MI; Bhatia KG; Barreiro C; Spangler G; Schvartzmann E; Muriel FS; Magrath IT
    Hum Mol Genet; 1994 Dec; 3(12):2247-8. PubMed ID: 7881428
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of beta-thalassaemia mutations using DNA heteroduplex generator molecules.
    Savage DA; Wood NA; Bidwell JL; Fitches A; Old JM; Hui KM
    Br J Haematol; 1995 Jul; 90(3):564-71. PubMed ID: 7646995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.
    Bhagirath T; Condie A; Dunlop MG; Wyllie AH; Prosser J
    Br J Cancer; 1993 Oct; 68(4):712-4. PubMed ID: 8398698
    [No Abstract]   [Full Text] [Related]  

  • 14. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
    Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
    Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
    Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex replication error causes p53 mutation in a Li-Fraumeni family.
    Strauss EA; Hosler MR; Herzog P; Salhany K; Louie R; Felix CA
    Cancer Res; 1995 Aug; 55(15):3237-41. PubMed ID: 7614454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction heteroduplex polymorphism analysis by entangled solution capillary electrophoresis.
    Cheng J; Kasuga T; Mitchelson KR; Lightly ER; Watson ND; Martin WJ; Atkinson D
    J Chromatogr A; 1994 Aug; 677(1):169-77. PubMed ID: 7951979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology.
    Belli C; De Brasi C; Larripa I
    Hum Mutat; 2003 Feb; 21(2):132-7. PubMed ID: 12552560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel human pathological mutations. Gene symbol: TP53. Disease: Li-Fraumeni syndrome.
    Saxena R; Kohli S; Guleria K; Verma IC
    Hum Genet; 2010 Apr; 127(4):480. PubMed ID: 21488255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.